Prevent

Steps can be taken to reduce the risk of VTE in active cancer patients. Primary prevention is the most effective way to reduce the negative outcomes associated with CAT. 13 
View presentation

Cancer

Cancer has multiple processes that increase the risk of hyper-coagulation. 6  Learn about the correlation between cancer and VTE in the presentation.
View presentation

Incidence

Over 50% of VTE occurs within the first 3 months of cancer diagnosis and differs between different types of cancer, and the risk differs between cancer type. 7,8  
View presentation

VTE risk factors

Chemotherapy, metastasis, obesity, age and surgery are just some of the factors that further increase the risk. Learn more about the risk factors for CAT in the presentation. 8

View presentation

Diagnose

Many cases of fatal PE are not clinically suspected or treated.9 As patients are often unaware of the signs and symptoms of CAT, recognition and targeted support are top priorities.10,11 
View presentation

Treat

According to international guidelines, anticoagulation should be continued 3-6 months for the treatment of VTE in cancer patients. 12  Learn more about the treatment recommendations in the presentation.
View presentation

Cancer 

Cancer has multiple processes that increase the risk of hyper-coagulation. 6  Learn about the correlation between cancer and VTE here.

Incidence

Over 50% of VTE occurs within the first 3 months of cancer diagnosis and differs between different types of cancer, and the risk differs between cancer type. 7,8  Learn about the incidence of CAT here.

VTE risk factors

Chemotherapy, metastasis, obesity, age and surgery are just some of the factors that further increase the risk. Learn more about the risk factors for CAT here. 8

Diagnose

Many cases of fatal PE are not clinically suspected or treated.9 As patients are often unaware of the signs and symptoms of CAT, recognition and targeted support are top priorities.10,11 Learn more about the diagnosis of CAT here.

Treat

According to international guidelines, anticoagulation should be continued 3-6 months for the treatment of VTE in cancer patients. 12  Learn more about the treatment recommendations here.

Prevent

Steps can be taken to reduce the risk of VTE in active cancer patients. Primary prevention is the most effective way to reduce the negative outcomes associated with CAT. 13  Learn more about prophylaxis here.